A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- lin Shen
Peking University Cancer Hospital & Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
49 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anhui Provincial Hospital
Hefei, Anhui, China
Recruiting - the First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Recruiting - the Second Hospital of Anhui Medical University
Hefei, Anhui, China
Recruiting - Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Recruiting - Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Recruiting - Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Recruiting - Chongqing Cancer Hospital
Chongqing, Chongqing Municipality, China
Recruiting - Fujian Cancer Hospital
Fuzhou, Fujian, China
Recruiting - Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Recruiting - the First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China
Recruiting - the First Affiliated Hospital,sun Yat-Sen University
Guangzhou, Guangdong, China
Recruiting - Sun Yat-Sen University Cancer Center
Guanzhou, Guangdong, China
Recruiting - Guangxi Medical University Cancer Hospital & Guangxi Cancer Institute
Nanning, Guangxi, China
Recruiting - Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou, China
Recruiting - Sir Run Run Shaw Hospital
Hangzhou, Hangzhou, China
Recruiting - Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Recruiting - Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
Recruiting - Anyang Tumor Hospital
Anyang, Henan, China
Recruiting - the First Affilated Hospital of Henan University of Science & Technology
Luoyang, Henan, China
Recruiting - Henan Cancer Hospital
Zhengzhou, Henan, China
Recruiting - Henan Provincial People'S Hospital
Zhengzhou, Henan, China
Recruiting - the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Recruiting - Hubei Cancer Hospital
Wuhan, Hubei, China
Recruiting - Tongji Hospital
Wuhan, Hubei, China
Recruiting - Wuhan Union Hospital of China
Wuhan, Hubei, China
Recruiting - Xiangyang Central Hospital
Xiangyang, Hubei, China
Recruiting - Hunan Cancer Hospital
Changsha, Hunan, China
Recruiting - Jiangsu Cancer Hospital
Nanjing, Jiangsu, China
Recruiting - Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
Recruiting - Nanjing First Hospital
Nanjing, Jiangsu, China
Recruiting - the Ferst Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Recruiting - the Second Affiliated Hospital Nanchang University
Nanchang, Jiangxi, China
Recruiting - the First Hospital of Jilin University
Ch’ang-ch’un, Jilin, China
Recruiting - Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, China
Recruiting - the First Hospital of China Medical University
Shenyang, Liaoning, China
Recruiting - Qilu Hospital of Shandong University
Jinan, Shandong, China
Recruiting - Shandong Cancer Hospital & Institute
Jinan, Shandong, China
Recruiting - Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Recruiting - Shanxi Bethune Hospital
Taiyuan, Shanxi, China
Recruiting - Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jan 2022
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 30 Jun 2026
- Registered enrollment
- 396
- Registry id
- NCT05170958
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.